Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review

Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005–2010)

(2012) Chunjiang Zhao et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)

(2012) Neil Fishman et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?

(2012) V. Cattoir et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins

(2012) J. Pogliano et al.   JOURNAL OF BACTERIOLOGY

Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan

(2012) Chien-Hsuan Chou et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

The rise of the Enterococcus: beyond vancomycin resistance

(2012) Cesar A. Arias et al.   NATURE REVIEWS MICROBIOLOGY

Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients

(2012) Shawna Kraft et al.   SUPPORTIVE CARE IN CANCER

Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007–2009 study

(2011) Heather J. Adam et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Vancomycin-resistant Enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin

(2011) Jennifer D. Twilla et al.   Journal of Hospital Medicine

Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians

(2010) T. Kelesidis et al.   CLINICAL INFECTIOUS DISEASES

Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

(2010) Christopher W. Crank et al.   CLINICAL THERAPEUTICS

Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents

(2010) J. A. McKINNELL et al.   EPIDEMIOLOGY AND INFECTION

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

A potential role for daptomycin in enterococcal infections: what is the evidence?

(2010) R. Canton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotics for Gram-Positive Bacterial Infections: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin, Dalbavancin, and Telavancin

(2009) Michael D. Nailor et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

(2009) John F. Mohr et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?

(2009) V. Mave et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY